Philip H. Coelho, Director at Catalyst Pharmaceutical Partners, Inc. (CPRX), bought 20,000 shares at $0.79 ($15K) on 2009-11-13, disclosed to the SEC on 2009-11-16.
Open-market purchase of $15k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.79 | 10,000 | $8K | 51.1% |
| 2 | $0.75 | 5,000 | $4K | 24.3% |
| 3 | $0.76 | 5,000 | $4K | 24.6% |
| Total | $0.77 avg | 20,000 | $15K | 100% |
| Filing → |
| CPRX | SELL | 2021-08-26 | $264K | — | Filing → |
| AMPE | SELL | 2021-05-25 | $13K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $7K | — | Filing → |